share_log

Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

Aleafia Health宣布多伦多证交所决定将退市审查期延长至2022年11月29日
GlobeNewswire ·  2022/09/16 06:00

TORONTO, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) ("Aleafia Health" or the "Company") announces that the Toronto Stock Exchange ("TSX") issued a decision today to extend its delisting review period until November 29, 2022. The Company will provide further updates as warranted.

多伦多，9月2022年16日(Global Newswire)--继之前宣布的消息后，Aleafia Health Inc.(多伦多证券交易所股票代码：AH，OTCQX：ALEAF)(Aleafia Health“或”公司“)宣布多伦多证券交易所(”多伦多证券交易所“)今天发布了一项决定，将退市审查期延长至2022年11月29日。公司将根据需要提供进一步的更新。

For Investor & Media Relations:

投资者和媒体关系：

Matthew Sale, CFO
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE:

首席财务官马修·赛尔
1-833-879-2533
邮箱：IR@AleafiaHealth.com
了解详细信息：

About Aleafia Health:

关于Aleafia Health:

The Company is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada.

该公司是一家获得联邦许可的加拿大大麻公司，在加拿大成人使用和医疗市场以及包括澳大利亚和德国在内的特定国际市场提供大麻产品。该公司经营着一个虚拟医用大麻诊所，由医生和护士从业人员组成，在加拿大各地提供健康和保健服务。


声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发